Oncology Research2025，Vol.33Issue(4)：P.919-935,17.DOI:10.32604/or.2024.054537
ERLNs augment simultaneous delivery of GFSV into PC-3 cells:Influence of drug combination on SDH,GPX-4,5α-RD,and cytotoxicity
RIYAD F.ALZHRANI 1LAMA BINOBAID 2ABDULAZIZ A.ALORAINI 1MESHAL S.ALSAHLI 1AHMED H.BAKHEIT 3HANADI H.ASIRI 3SABRY M.ATTIA 2ALI ALHOSHANI 2GAMALELDIN I.HARISA1
作者信息
- 1. Department of Pharmaceutics,College of Pharmacy,King Saud University,Riyadh,11451,Saudi Arabia
- 2. Department of Pharmacology and Toxicology,College of Pharmacy,King Saud University,Riyadh,11451,Saudi Arabia
- 3. Department of Pharmaceutical Chemistry,College of Pharmacy,King Saud University,Riyadh,11451,Saudi Arabia
- 折叠
摘要
关键词
Prostate cancer(PCA)/Nanoparticle biocompatibility/Molecular docking simulation(MDS)/Apoptosis/Drug repurposing分类
医药卫生引用本文复制引用
RIYAD F.ALZHRANI,LAMA BINOBAID,ABDULAZIZ A.ALORAINI,MESHAL S.ALSAHLI,AHMED H.BAKHEIT,HANADI H.ASIRI,SABRY M.ATTIA,ALI ALHOSHANI,GAMALELDIN I.HARISA..ERLNs augment simultaneous delivery of GFSV into PC-3 cells:Influence of drug combination on SDH,GPX-4,5α-RD,and cytotoxicity[J].Oncology Research,2025,33(4):P.919-935,17.
